Potential Applications of Digital Pathology and Image Analysis for Forensic Pathology

2012 ◽  
Vol 2 (1) ◽  
pp. 74-79 ◽  
Author(s):  
Bruce P. Levy ◽  
Jason D. Hipp ◽  
Ulysses J. Balis ◽  
Yukako Yagi
2021 ◽  
pp. jclinpath-2020-207351
Author(s):  
Jenny Fitzgerald ◽  
Debra Higgins ◽  
Claudia Mazo Vargas ◽  
William Watson ◽  
Catherine Mooney ◽  
...  

Clinical workflows in oncology depend on predictive and prognostic biomarkers. However, the growing number of complex biomarkers contributes to costly and delayed decision-making in routine oncology care and treatment. As cancer is expected to rank as the leading cause of death and the single most important barrier to increasing life expectancy in the 21st century, there is a major emphasis on precision medicine, particularly individualisation of treatment through better prediction of patient outcome. Over the past few years, both surgical and pathology specialties have suffered cutbacks and a low uptake of pathology specialists means a solution is required to enable high-throughput screening and personalised treatment in this area to alleviate bottlenecks. Digital imaging in pathology has undergone an exponential period of growth. Deep-learning (DL) platforms for hematoxylin and eosin (H&E) image analysis, with preliminary artificial intelligence (AI)-based grading capabilities of specimens, can evaluate image characteristics which may not be visually apparent to a pathologist and offer new possibilities for better modelling of disease appearance and possibly improve the prediction of disease stage and patient outcome. Although digital pathology and AI are still emerging areas, they are the critical components for advancing personalised medicine. Integration of transcriptomic analysis, clinical information and AI-based image analysis is yet an uncultivated field by which healthcare professionals can make improved treatment decisions in cancer. This short review describes the potential application of integrative AI in offering better detection, quantification, classification, prognosis and prediction of breast and prostate cancer and also highlights the utilisation of machine learning systems in biomarker evaluation.


Pathobiology ◽  
2016 ◽  
Vol 83 (2-3) ◽  
pp. 148-155 ◽  
Author(s):  
Daniel Racoceanu ◽  
Frédérique Capron

2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Alaa Khadidos ◽  
Adil Khadidos ◽  
Olfat M. Mirza ◽  
Tawfiq Hasanin ◽  
Wegayehu Enbeyle ◽  
...  

The word radiomics, like all domains of type omics, assumes the existence of a large amount of data. Using artificial intelligence, in particular, different machine learning techniques, is a necessary step for better data exploitation. Classically, researchers in this field of radiomics have used conventional machine learning techniques (random forest, for example). More recently, deep learning, a subdomain of machine learning, has emerged. Its applications are increasing, and the results obtained so far have demonstrated their remarkable effectiveness. Several previous studies have explored the potential applications of radiomics in colorectal cancer. These potential applications can be grouped into several categories like evaluation of the reproducibility of texture data, prediction of response to treatment, prediction of the occurrence of metastases, and prediction of survival. Few studies, however, have explored the potential of radiomics in predicting recurrence-free survival. In this study, we evaluated and compared six conventional learning models and a deep learning model, based on MRI textural analysis of patients with locally advanced rectal tumours, correlated with the risk of recidivism; in traditional learning, we compared 2D image analysis models vs. 3D image analysis models, models based on a textural analysis of the tumour versus models taking into account the peritumoural environment in addition to the tumour itself. In deep learning, we built a 16-layer convolutional neural network model, driven by a 2D MRI image database comprising both the native images and the bounding box corresponding to each image.


2022 ◽  
pp. 395-421
Author(s):  
Famke Aeffner ◽  
Thomas Forest ◽  
Vanessa Schumacher ◽  
Mark Zarella ◽  
Alys Bradley

Methods ◽  
2014 ◽  
Vol 70 (1) ◽  
pp. 59-73 ◽  
Author(s):  
Peter W. Hamilton ◽  
Peter Bankhead ◽  
Yinhai Wang ◽  
Ryan Hutchinson ◽  
Declan Kieran ◽  
...  

2017 ◽  
Vol 45 (7) ◽  
pp. 983-1003 ◽  
Author(s):  
Chandra Saravanan ◽  
Vanessa Schumacher ◽  
Danielle Brown ◽  
Robert Dunstan ◽  
Jean-Rene Galarneau ◽  
...  

Quantitative image analysis (IA) is a rapidly evolving area of digital pathology. Although not a new concept, the quantification of histological features on photomicrographs used to be cumbersome, resource-intensive, and limited to specialists and specialized laboratories. Recent technological advances like highly efficient automated whole slide digitizer (scanner) systems, innovative IA platforms, and the emergence of pathologist-friendly image annotation and analysis systems mean that quantification of features on histological digital images will become increasingly prominent in pathologists’ daily professional lives. The added value of quantitative IA in pathology includes confirmation of equivocal findings noted by a pathologist, increasing the sensitivity of feature detection, quantification of signal intensity, and improving efficiency. There is no denying that quantitative IA is part of the future of pathology; however, there are also several potential pitfalls when trying to estimate volumetric features from limited 2-dimensional sections. This continuing education session on quantitative IA offered a broad overview of the field; a hands-on toxicologic pathologist experience with IA principles, tools, and workflows; a discussion on how to apply basic stereology principles in order to minimize bias in IA; and finally, a reflection on the future of IA in the toxicologic pathology field.


Sign in / Sign up

Export Citation Format

Share Document